David E Cohen
Director at Evommune, Inc. (EVMN)
David E Cohen has filed 7 insider reports with the SEC since May 2021, as director at Evommune, Inc. (EVMN), director at Timber Pharmaceuticals, Inc. (TMBR) and director at Kadmon Holdings, Inc. (KDMN). In the last 12 months David E Cohen sold $123K of stock on the open market. In the latest filing, on June 4, 2026, David E Cohen sold 6,056 shares of Evommune, Inc. (EVMN) for $123K at an average of $20.33.
- Filings
- 7
- Companies
- 3
- Bought on market
- None
- Sold on market
- $123K
Companies where David E Cohen is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 17,609 | $123K | $7.63 | Jun 4, 2026 | |||
| Director | 6,100 | Apr 18, 2023 | |||||
| Director | Nov 9, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 2, 2026-$123KEVMNDirector Cohen David E sold $123,094 worth of shares (6,056 units at $20.33) as part of a pre-agreed trading plan, decreasing direct ownership by 26% to 17,609 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Jun 2, 2026~$205KEVMNDavid E Cohen plans to sell 9,258 shares (~$205K)Form 144Planned sale10b5-1 plan
- Apr 15, 2023TMBRSEC Form 4 filed by Cohen David EForm 4Grant or award
- Apr 15, 2022TMBRSEC Form 4: Cohen David E was granted 100,000 sharesForm 4Grant or award
- Nov 9, 2021KDMNSEC Form 4 filed by Cohen David EForm 4Sale back to the company
- Jul 1, 2021TMBRSEC Form 4 filed by Cohen David EForm 4Grant or award
- May 12, 2021KDMNSEC Form 4 filed by Cohen David EForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with David E Cohen.
- Kyle Carver2 shared: EVMN, KDMN
- Arthur S Kirsch2 shared: EVMN, KDMN
- Gregory S. Moss2 shared: EVMN, KDMN
- Eugene Bauer2 shared: EVMN, KDMN
Compare David E Cohen with
- David E Cohen vs Kyle Carver2 shared
- David E Cohen vs Arthur S Kirsch2 shared
- David E Cohen vs Gregory S. Moss2 shared
- David E Cohen vs Eugene Bauer2 shared
- David E Cohen vs Janice Suzann Drew1 shared
- David E Cohen vs Jeegar Pravinkumar Patel1 shared
Other insiders at the same companies
- Janice Suzann DrewEVMN
- Jeegar Pravinkumar PatelEVMN
- Luis C. PenaEVMN
- Benjamin F Mcgraw IIIEVMN
- LSP 7 Cooperative UAEVMN
- Verduyn-van Weegen Felice IsabelEVMN
- Ra Capital Management, L.P.EVMN
- Robert Lorne HopfnerEVMN
Questions about David E Cohen
- What is David E Cohen's role at Evommune, Inc.?
- David E Cohen reports to the SEC as director at Evommune, Inc. (EVMN), according to the latest filing on June 4, 2026. David E Cohen has also filed as director at Timber Pharmaceuticals, Inc. (TMBR) and director at Kadmon Holdings, Inc. (KDMN).
- How many shares does David E Cohen own?
- After the latest filing that states it, David E Cohen directly owned 17,609 shares of Evommune, Inc. (EVMN) and 6,100 shares of Timber Pharmaceuticals, Inc. (TMBR). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has David E Cohen bought or sold stock recently?
- The most recent open-market sale was on June 2, 2026: sold 6,056 shares of Evommune, Inc. (EVMN) for $123K at an average of $20.33.
- How do I get alerts when David E Cohen files?
- Follow David E Cohen on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by David E Cohen (SEC CIK 0001347383). Totals count each trade once, skipping amendments whose original is on file, from May 13, 2021 on. View on SEC EDGAR